TAKEDA PHARMACEUTICAL COMPANY LIMITED Takeda Pharmaceutical Company Limited Share Price Sao Paulo
Equities
TAKP34
BRTAKPBDR006
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.26 BRL | +2.93% |
|
+6.23% | +3.04% |
| 06:00am | Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India | MT |
| 06-04 | Transcript : Takeda Pharmaceutical Company Limited - Special Call |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 | 4,264B 27.39B 145B 2,141B | Sales 2025 * | 4,252B 27.31B 145B 2,135B | Capitalization | 6,613B 42.48B 225B 3,321B |
|---|---|---|---|---|---|
| Net income 2024 | 144B 925M 4.91B 72.35B | Net income 2025 * | 116B 748M 3.97B 58.48B | EV / Sales 2024 | 1.54 x |
| Net Debt 2024 * | 3,771B 24.22B 128B 1,894B | Net Debt 2025 * | 4,224B 27.14B 144B 2,121B | EV / Sales 2025 * | 2.55 x |
| P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
59.8
x | Employees | 49,095 |
| Yield 2024 |
4.49% | Yield 2025 * |
4.6% | Free-Float | 99.12% |
More Fundamentals
* Assessed data
More news
Latest transcript on Takeda Pharmaceutical Company Limited
More recommendations
More press releases
More news
| 1 day | +2.93% | ||
| 1 week | +6.23% | ||
| Current month | +2.00% | ||
| 1 month | +5.46% | ||
| 3 months | -0.39% | ||
| 6 months | +2.93% | ||
| Current year | +3.04% |
1 week
69.44
71.26
1 month
66.4671.26
Current year
66.4674.20
1 year
66.4679.55
3 years
66.1092.00
5 years
66.1092.00
10 years
66.1092.00
| Managers | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 31/03/14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/01/22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 31/12/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 31/05/16 | |
Ian Clark
BRD | Director/Board Member | 62 | 31/12/18 |
Steven Gillis
BRD | Director/Board Member | 71 | 31/12/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/06/24 | 71.26 | +1.09% | 1 |
| 04/06/24 | 70.49 | +0.90% | 1 |
| 31/05/24 | 69.86 | +4.14% | 8 |
Delayed Quote Sao Paulo, June 05, 2024 at 07:30 pm
More quotes
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:
- sale of drugs and consumer care products;
- services.
Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Sector
Pharmaceuticals
Calendar
25/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,215
JPY
Average target price
4,790
JPY
Spread / Average Target
+13.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +42.69% | 750B | |
| +34.11% | 606B | |
| -6.87% | 356B | |
| +18.74% | 326B | |
| +6.76% | 286B | |
| +18.08% | 246B | |
| -3.44% | 213B | |
| +11.35% | 213B | |
| +2.64% | 167B |
- Stock Market
- Equities
- 4502 Stock
- TAKP34 Stock
